1,667
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Searching for drug leads targeted to the hydrophobic cleft of dengue virus capsid protein

, ORCID Icon, , , , , & ORCID Icon show all
Pages 287-298 | Received 12 Sep 2021, Accepted 03 Nov 2021, Published online: 11 Dec 2021
 

Abstract

We synthesised and screened 18 aromatic derivatives of guanylhydrazones and oximes aromatic for their capacity to bind to dengue virus capsid protein (DENVC). The intended therapeutic target was the hydrophobic cleft of DENVC, which is a region responsible for its anchoring in lipid droplets in the infected cells. The inhibition of this process completely suppresses virus infectivity. Using NMR, we describe five compounds able to bind to the α1-α2 interface in the hydrophobic cleft. Saturation transfer difference experiments showed that the aromatic protons of the ligands are important for the interaction with DENVC. Fluorescence binding isotherms indicated that the selected compounds bind at micromolar affinities, possibly leading to binding-induced conformational changes. NMR-derived docking calculations of ligands showed that they position similarly in the hydrophobic cleft. Cytotoxicity experiments and calculations of in silico drug properties suggest that these compounds may be promising candidates in the search for antivirals targeting DENVC.

Acknowledgements

The author IPC gratefully acknowledges the financial support by a postdoctoral fellowship from FAPERJ and the PROPe UNESP. The author LOO was a fellow of CAPES.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro – FAPERJ, Brazil: Grant [255.940/2020, 202.279/2018, 239.229/2018, 202.945/2017, 201.316/2016, 210.361/2015, and 204.432/2014]. Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq, Brazil: [439306/2018–3, 309564/2017–4, and 309028/2017–5. La Caixa Bank Foundation, Spain: LCF/PR/HR17/52150011].